Lab report · CJC-1295 no DAC + Ipamorelin Blend · Purity & amount
Reports describe submitted samples for this amount and form.
CJC-1295 no DAC + Ipamorelin Blend
This blend combines CJC-1295 no DAC and Ipamorelin, which come from different growth-hormone signaling pathways.
What does the amount mean?
10 mg is an amount of material. Read the label to see whether it means per vial, per tablet, or per package.
Read more1 vial
You can add this product to your cart. Checkout is temporarily unavailable.
Lab resultsCJC-1295 no DAC + Ipamorelin Blend, explained
This blend combines CJC-1295 no DAC and Ipamorelin, which come from different growth-hormone signaling pathways.
What it’s used for
CJC-1295 no DAC + Ipamorelin Blend combines two named peptides from growth hormone-signaling research: the GHRH category and the ghrelin-receptor secretagogue category.
CJC-1295 no DAC + Ipamorelin Blend combines two named components from growth-hormone-signaling research. CJC-1295 no DAC is listed in the GHRH category. Ipamorelin activates the ghrelin receptor, a separate route involved in growth hormone release.
The pairing brings those two research categories into one blend, with interest centered on how different hormone-release signals interact.
- Research interests
- Growth-hormone signals · Recovery · Two-peptide blend
This combination is not established by studies of either ingredient alone.
Side effects & safety
This combination is not established by studies of either ingredient alone.
What the evidence covers
Named molecule in the cited setting; not independent testing of Monroe stock.
Exact formulation matters
Studies of one ingredient do not establish the effects or safety of the combined formulation.
Sample testing and human safety
A sample's purity, content or endotoxin report answers a different question from clinical safety. It does not establish the safety or suitability of this product for a person.
How much people usually take
The labelled amount of CJC-1295 no DAC + Ipamorelin Blend describes the listing quantity, not a personal dose.
No direct human studies verified. This combination is not established by studies of either ingredient alone. Trial amounts, schedules and monitoring belong to the specific study formulation and population; they cannot be converted into instructions for this listing.
A usual amount is not reported in the linked sources.
How to mix and store it
CJC-1295 no DAC + Ipamorelin Blend is a combined formulation, so its ingredients need separate attention.
A total label amount does not identify the amount of each ingredient. No formula-specific solvent, final volume, stability period or compatibility instructions are supplied here.
- Recorded presentation
- Presentation not specified
Combining it with others
CJC-1295 no DAC + Ipamorelin Blend already combines named materials; component research is not evidence for the mixture.
The blend needs its own confirmed composition. Individual-ingredient findings do not establish combined behavior, stability or interaction risk; unspecified component quantities remain unknown.
What the research says
No direct human studies verified. Named molecule in the cited setting; not independent testing of Monroe stock.
These selected sources support the stated mechanism or research setting. They are not a systematic review, a test of Monroe inventory or an independent assessment of the finished product.
CJC-1295 albumin conjugate and GRF receptor study
Supports general GHRH-family context, not an exact no-DAC identity or blend outcome.
Ipamorelin ghrelin-receptor experiments in rats
Identifies ipamorelin as a ghrelin receptor agonist and growth hormone secretagogue; does not study this blend.
Lab results
CJC-1295 no DAC + Ipamorelin Blend · 1 linked report
- Amount found · CJC-1295 (mod GRF 1-29)
- Sample 1: 5.92 mgSample 2: 6.11 mgSample 3: 6.07 mg
- Amount found · Ipamorelin
- Sample 1: 5.21 mgSample 2: 5.46 mgSample 3: 5.42 mg
Separate sample results, in report order.
Purity & amount
Sample batch CJCIPA04
These are submitted-sample results, separate from general research or popularity ratings. Report presentation: Peptify Analytics. Source laboratory: Janoshik Analytical. The connection to the batch you would receive is not confirmed here.
Videos worth watching
Research conversations, with their original context.
Video resources are not available for this guide.
Read the original sourcesProduct details
- Form
- Unspecified
- Amount
- CJC-1295 no DAC + Ipamorelin Blend
Sources & further reading
Follow each reference to its original publication or documentation.
Questions
What does the labelled amount mean?
It describes an amount of material in the unit stated on the label. It does not describe liquid volume, a dose, or how to prepare the product.
Read more about amountsDoes purity mean it is sterile?
No. Purity and sterility require different tests. An endotoxin result also does not establish sterility.
About testingHow can I get help with an order?
Open your order details to check its current status. Shipping and support information are available below.
Contact usMore to explore
Shop allBPC-157 / TB-500 Blend
BPC-157 / TB-500 Blend brings two named research peptides into one product, with BPC-157 linked to connective-tissue studies and TB-500 to thymosin-beta-4 research.
Research material · Vial
6mg/6mg · 10mg/10mg
Brain Blend
Brain Blend combines Selank and Semax in one 6mg/6mg peptide blend, bringing together two distinct approaches to neurotransmitter and nerve-cell signaling research.
Research material · Vial
6mg/6mg
GLOW Blend
GLOW combines GHK-Cu, BPC-157 and TB-500 in a 70mg peptide blend, bringing ingredients from copper-peptide and connective-tissue research into one vial format.
Research material · Vial
70mg
KLOW Blend
KLOW combines KPV, GHK-Cu, TB-500 and BPC-157 in an 80mg peptide blend, adding an inflammatory-signaling research component to the four-peptide formula.
Research material · Vial
80mg